Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion type Assertion NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_head.
- NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion description "[Polymorphic variations in the MTR, SLC19A1, and TYMS genes were associated with better clinical response to combination DMARD regimens containing MTX and SSZ.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_provenance.
- NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion evidence source_evidence_literature NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_provenance.
- NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion SIO_000772 18322994 NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_provenance.
- NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion wasDerivedFrom gad-20130706 NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_provenance.
- NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_assertion wasGeneratedBy ECO_0000203 NP62111.RA5U4FhET_IfA8BCWXvIEaROnYsmJTnhyI-pYfEyCxCWY130_provenance.